Solifenacin Pharmaceutical Reference Standards
Aligns Pharma science supply high-quality impurities reference standards of Solifenacin, pharmacopeial and non-pharmacopeial Solifenacin impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Solifenacin impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Solifenacin is a muscarinic receptor antagonist drug used for treating contraction of overactive bladder such as incontinence, urinary frequency, and urgency. Solifenacin is a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. It was manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries.
Our Solifenacin impurities reference standard offering includes